Related Experiment Video
Updated: Nov 10, 2025

The Cultivation, Growth, and Viability of Lactic Acid Bacteria: A Quality Control Perspective
Published on: June 16, 2022
Developing Lactic Acid Bacteria as an Oral Healthy Food
Wei-Kuang Lai1, Ying-Chen Lu2, Chun-Ren Hsieh2
1Graduate Institute of Natural Products, Kaohsiung Medical University, College of Pharmacy, Kaohsiung 807, Taiwan.
Lactic acid bacteria effectively inhibit oral pathogens like Streptococcus mutans and Porphyromonas gingivalis. A developed oral tablet containing Lacticaseibacillus paracasei strains significantly reduced these pathogens in a clinical trial.
Area of Science:
- Microbiology
- Oral Health
- Probiotics
Background:
- Lactic acid bacteria (LAB) possess known functions in immunoregulation, antagonism, and pathogen inhibition.
- Oral pathogens, such as Streptococcus mutans (caries) and Porphyromonas gingivalis (periodontal disease), pose significant health challenges.
- Developing effective strategies to control these pathogens is crucial for maintaining oral hygiene.
Purpose of the Study:
- To evaluate the efficacy of lactic acid bacteria (LAB) in combating oral pathogens.
- To develop novel oral health products utilizing specific LAB strains.
- To investigate the mechanisms behind LAB's pathogen inhibition, including bacteriocins and coaggregation.
Main Methods:
- Screening of 450 LAB strains for inhibitory effects against Streptococcus mutans and Porphyromonas gingivalis.
- Selection of potent strains, Lacticaseibacillus paracasei 111 and Lacticaseibacillus paracasei 141, for further development.
- Optimization of cultural conditions for selected LAB strains and formulation of an oral tablet.
- Conducting a clinical study with 40 volunteers to assess the tablet's impact on oral pathogens and periodontal health.
Main Results:
- Eight heat-inactivated LAB strains demonstrated strong inhibition against Streptococcus mutans.
- 308 heat-inactivated LAB strains exhibited strong inhibition against Porphyromonas gingivalis.
- The developed oral tablet, containing Lacticaseibacillus paracasei 111 and 141, showed a 446-day shelf life.
- Clinical trial results indicated a 95% reduction in periodontal pathogens and a 78.9% improvement in probing pocket depth after 8 weeks.
Conclusions:
- Lactic acid bacteria, particularly Lacticaseibacillus paracasei strains, are effective in inhibiting key oral pathogens.
- Bacteriocin production and coaggregation are significant mechanisms for LAB's pathogen inhibition.
- The developed oral tablet represents a promising probiotic intervention for improving oral health and managing periodontal disease.
Related Concept Videos
Microorganisms in Agriculture and Food industry
Bacterial Phylum Firmicutes
Microbial Fermentation
Oral Cavity
Teeth: The teeth are the hardest structures in our bodies. Humans have two sets of teeth throughout their lifetime: deciduous (baby) teeth and permanent teeth. Each tooth consists of several parts: the crown (visible part), the root (embedded in the jaw), enamel (hard outer...
Bacterial Flora of the Large Intestine
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
What is Monogastric Digestion?

